Lung Cancer · 2019 · 28 citations · 19 references
MedicineOncologyPharmacologyCancer PharmacologyMedical OncologyMolecular OncologyCancer ProgressionLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsTargeted Cancer TherapyTyrosine Kinase InhibitorsAlk Fusion GenesAlk InhibitionAlk Point MutationsAnaplastic Lymphoma Kinase InhibitionAnaplastic Lymphoma Kinase InhibitorsNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer Treatment
19
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer
Benjamin Solomon, Tony Mok, Dong‐Wan Kim et al. · New England Journal of Medicine · 2014 · 3.2K citations · Full text
Medicine, Oncology, Pharmacology +12
Ceritinib in <i>ALK</i> -Rearranged Non–Small-Cell Lung Cancer
Alice T. Shaw, Dong-Wan Kim, Ranee Mehra et al. · New England Journal of Medicine · 2014 · 1.5K citations
Medicine, Oncology, Pharmacology +14